REGN logo

REGN
Regeneron Pharmaceuticals, Inc.

17,593
Mkt Cap
$107.33B
Volume
793,326.00
52W High
$821.11
52W Low
$476.49
PE Ratio
19.03
REGN Fundamentals
Price
$790.81
Prev Close
$781.67
Open
$771.10
50D MA
$771.06
Beta
0.60
Avg. Volume
751,970.32
EPS (Annual)
$41.48
P/B
2.67
Rev/Employee
$930,752.76
$78,186.98
Loading...
Loading...
News
all
press releases
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $765.00 at Royal Bank Of Canada
Royal Bank Of Canada increased their price target on shares of Regeneron Pharmaceuticals from $745.00 to $765.00 and gave the company a "sector perform" rating in a research report on Monday...
MarketBeat·10h ago
News Placeholder
More News
News Placeholder
REGN & SNY's Dupixent Gets CHMP Nod for Pediatric Use in Urticaria
Regeneron and Sanofi win CHMP backing to expand Dupixent use to young CSU patients, with EU and U.S. decisions poised to unlock a new growth avenue.
Zacks·13h ago
News Placeholder
Rafferty Asset Management LLC Sells 6,156 Shares of Regeneron Pharmaceuticals, Inc. $REGN
Rafferty Asset Management LLC reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 11.7% in the third quarter, according to the company in its most recent Form 13F...
MarketBeat·2d ago
News Placeholder
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Cache Advisors LLC
Cache Advisors LLC reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 26.9% during the 3rd quarter, according to its most recent 13F filing with the SEC...
MarketBeat·2d ago
News Placeholder
Handelsbanken Fonder AB Boosts Holdings in Regeneron Pharmaceuticals, Inc. $REGN
Handelsbanken Fonder AB grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 24.8% in the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·3d ago
News Placeholder
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by American Century Companies Inc.
American Century Companies Inc. grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 3.8% during the 3rd quarter, according to the company in its most recent...
MarketBeat·3d ago
News Placeholder
Regeneron Pharmaceuticals (NASDAQ:REGN) Raised to "Buy" at Wall Street Zen
Wall Street Zen raised Regeneron Pharmaceuticals from a "hold" rating to a "buy" rating in a report on Saturday...
MarketBeat·3d ago
News Placeholder
Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline
NTLA shares jump after fourth-quarter earnings and revenues exceed expectations. The company focuses on lonvo-z and nex-z pipeline programs.
Zacks·3d ago
News Placeholder
Erste Asset Management GmbH Sells 4,661 Shares of Regeneron Pharmaceuticals, Inc. $REGN
Erste Asset Management GmbH trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 8.7% in the third quarter, according to its most recent Form 13F filing with the...
MarketBeat·4d ago
News Placeholder
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Banco Santander S.A.
Banco Santander S.A. increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 263.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·4d ago
<
1
2
...
>

Latest REGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.